chrisvoncsefalvay/vaers-outcomes huggingface dataset:
previous to receiving the vaccine I was diagnosed with a high infection of Lyme disease, over time the symptoms worsened even after treatment , over a span of about ten years I have developed small fiber neuropathy, immune issues , chronic fatigue , muscle and joint pain , numbness and tingling in my hands and feet , issues with chronic weight and muscle loss . I was treated several times for the Lyme disease and even with treatments my symptoms never dissipated . In 2018 I started auto immune infusions and feel much better but still suffer with symptoms to this day . Before the vaccine I did not experience exacerbated symptoms . After the vaccine my symptoms worsened and I am unable to test negative for Lyme disease and Rocky Mountain spotted fever . It has been many years of testing high positive and experiencing symptoms .
Developed severe dizziness and the feeling that my head was "bobbing forward and back" upon walking or coming from a lying position to quickly sitting up. Being still eliminated the feeling. IT slowly improved to about 80% normalcy. Visited neurologist in August 2021 and he diagnosed it as Disembarkment syndrome. Although it does fit all the patterns of this diagnosis. For instance being still does not bother me and getting back on the moving object does not make it better or worse. I am only bothered when my head changes position quickly from back to front.
issue with her gallbladder; about 2 days after receiving the second dose of the vaccine the patient was hospitalized for dangerously low white blood cell counts. It resulted in multiple blood transfusions and a week long hospita; This is a spontaneous report from a contactable consumer (patient). A 94-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no known allergies, The patient was hospitalized for dangerously low white blood cell counts about 2 days after receiving the second dose of the vaccine. It resulted in multiple blood transfusions and a week long hospital visit. The patient returned home for about 2 months on an oxygen tank and was taken to the hospital again for low white blood cell counts and an issue with her gallbladder. She is still currently in the hospital. AE resulted in hospitalization, disability or permanent damage. Adverse event start date was on Feb2021. The patient recovered with lasting effects. treatment was received with AE. No Covid tested prior and post vaccination. No other vaccine received in four weeks. The patient underwent lab tests and procedures which included low white blood cell count dangerously on Feb2021.    Information on the lot/batch number has been requested.
Pt reports on 1/22/01 between 2-2:30pm - at 2am SOB, itching face, stomach, arms, legs,hives. Fast heart rate, went to ER was prescribed Prednizone, O2, inhaler breathing machine, Heparin lock to slow heart rate and breathing. Also pepcid, Rx for Prednizone, Atarax for itching.
Feel tired; Feel like im recovering from flu; Dont feel terrible; mildly sick; Tested positive for covid; This spontaneous case was reported by a physician and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid), FATIGUE (Feel tired), INFLUENZA (Feel like im recovering from flu), INAPPROPRIATE AFFECT (Dont feel terrible) and ILLNESS (mildly sick) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid). On an unknown date, the patient experienced FATIGUE (Feel tired), INFLUENZA (Feel like im recovering from flu), INAPPROPRIATE AFFECT (Dont feel terrible) and ILLNESS (mildly sick). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and HYDROXYCHLOROQUINE at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid) had not resolved and FATIGUE (Feel tired), INFLUENZA (Feel like im recovering from flu), INAPPROPRIATE AFFECT (Dont feel terrible) and ILLNESS (mildly sick) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, SARS-CoV-1 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator
Fatigue; Fever (100F); The patient received the third/booster dose of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via intramuscular route of administration in the left arm on 03Nov2021 at 11:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and known allergies to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), amlodipine besilate (MANUFACTURER UNKNOWN), fluoxetine (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via intramuscular route of administration in the left arm on 02Mar2021 at 14:00 (at the age of 57-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via intramuscular route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient previously also received ampicillin (MANUFACTURER UNKNOWN) taken for an unknown indication on an unknown date and experienced drug allergy. On 04Nov2021 at 07:00, the patient experienced fatigue and fever (100F) the following day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fatigue and fever (100F) were resolving at the time of this report.
Tylenol given on day of vaccine, due to temperature.  Second day post vaccine noted red papular-like eruptions throughout legs and trunk.
c/o rt ear hurting & redness;swelling behind rt ear;to ER swelling & pain; next day swelling worse;swelling over rt jaw to behind rt pinna;mom states swelling down onto neck;tenderness to even light palpation;dental caries on rt side;viral
Pt devel eyelid swelling approx 20 min p/receiving DTP/OPV/MMR immun & PPD Mantoux; No further progression to anaphylaxis; pt responded well to SQ Epi & discharged home w/o problems; rxn potentially life threatening;
Pronounced joint pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pronounced joint pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Pronounced joint pain). At the time of the report, ARTHRALGIA (Pronounced joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided by the reporter.    Reporter did not allow further contact
Joint pain, slight dizziness, complete exhaustion next day. Had to stay in bed for about 18 hours. 4 days later lymph node became enlarged in right armpit.
Discovery of sub therapeutic dose of vaccine. Pt received 0.3ml of Moderna vaccine; patient notified and returned to receive additional 0.2ml Moderna vaccine ; issue resolved
Red swelling near the site of injection that started off as a small red lump and grew to 3in x 1.5in over period of 48 hrs. No pain.
A bright patchy red rash suddenly appeared on my daughter's cheek with white raised spots.  That outbreak subsided within 30 minutes, but I counted 14 subsequent outbreaks of the rash all over her body over the next 48 hours, each appearing suddenly, then fading slowly, though spreading a bit more before disappearing within half hour.  No treatment given- By the time we purchased Benadryl per our pediatrician's instructions, the first outbreak had subsided, so after consult with the doctor, we decided not to use Benadryl on such a young baby if the rash were subsiding on its own.  We have decided not to complete this vaccination series.
Pt was admitted post cat bite and required OR intervention and therefore was tested for COVID and was positive.  Pt is asymptomatic.
This spontaneous report was received from a registered nurse regarding four unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with an improperly stored doses of VARIVAX (dose and route were not reported, lot # L006385, expiry date: 25-FEB-2017). There were no adverse effects reported. Follow up information was received on 02-OCT-2015. On 02-OCT-2015, a call was placed to the registered nurse and went directly to voice mail. A voice mail message was left requesting the nurse to return the phone call and requesting also for patients identifiers, lot number and expiration date and date of vaccination. All telephone attempts to obtain follow-up information have been unsuccessful. Follow up information has been received from the reporting nurse on 08-OCT-2015 and refers to a 12 month old patient of unknown gender. On 17-AUG-2015, the patient was vaccinated with a dose of improperly stored VARIVAX. The temperature excursion had place on 09-AUG-2015. This is one of several reports received from the same source. Additional information has been requested. Patient details and narrative were updated.
This spontaneous prospective pregnancy report as received from a nurse practitioner refers to a female patient of unknown age. Patient current condition included sulfa allergy and historical drug included sulfa drug. Dose 1 was administered 03-MAR-2014 (lot # H020848 exp: 03-APR-2015), Dose 2 was administered 29-MAY-2014 (lot# J011960 exp 06-AUG-2015) and Dose 3 was administered 05-NOV-2014 (lot # J006850 exp: 31-MAR-2016), dose: 5ml, intramuscular, right deltoid. After Dose 3 was administered it was discovered the patient was pregnant. Concomitant medications included multivitamin and unspecified oral contraceptive pill. It was reported that the patient was taking an oral contraceptive pill which has been discontinued now that it has been found the patient is pregnant. The patient became pregnant with last menstrual period (LMP) of 26-AUG-2014 and estimated delivery dare (EDD) of 02-JUN-2015. Lab test included urine pregnancy test. The patient sought medical attention. The pregnancy outcome was pending. Date of birth was confirmed. No other details was provided. Additional information has been requested.
Two weeks after vaccine given developed headache, fever, chills, dizziness. Two days later "mosquito bite like" bumps on body, thought to be chicken pox. Developed approx. 100 pox to entire body. Lasted about 2 weeks, then resolved.
Today 10/27/2021, patient reported right half of face, right side of scalp, and right upper arm are numbed and tingling.  Still have those symptoms after her 2nd dose of Pfizer covid vaccine on 8/30/21.  Symptoms start about 3 -4 days after 2nd dose of Pfizer. She read that it could be months until it resolves.
Vaccine DTaP and MMR given 7/16/02 at health department. On 7/28/02, presented to ER with itching and rash. Solumedrol and Benadryl given. Follow up in office on 08/02/02; symptoms gone.
COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from a non-contactable reporter(s) (Nurse) from product quality group. The reporter is the patient.  An adult female patient received BNT162b2 (BNT162B2), as dose 2, single (Lot number: EW0182) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Gerd" (unspecified if ongoing); "Migraines" (unspecified if ongoing); "known allergies: latex" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Tetracycline, reaction(s): "known allergies: Tetracycline". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient Age group was reported as Adult (18-64 Years). Patient did not receive any other medication within 2 weeks of vaccination. Paxlovid (Lot no Lot number: GD7763) was used as treatment for Covid-19 from 27Jul2022 to 28Jul2022. Patient experienced Severe abdominal cramping and pain and watery diarrhea after paxlovid.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
Multisystem Inflammatory Response to the vaccine with fever for 5 days, elevated LFT's, low Na, low platelets, elevated CPK. Patient hospitalized for 2 days.
My son woke up with pain, redness and swelling at the injection site on upper arm. Then he developed a low fever, lost his appetite, became tired, achey and lethargic for about 4 days. He had pain and swelling in his face and neck. While sleeping at night, his fever would increase to about 101 or more and he had the sweats and chills. I reported this reaction to his doctor but did not take him back in because there isn't anything they could have done, they recommended Tylenol.
Pt received Fluzone Quad IM in the left arm and vaccine leaked onto both sides of her arm.  After vaccine administration, Pt's mother warned pharmacy that patient had expressed feeling lightheadedness, with clammy skin for approxmiately 5 minutes.  Orange juice was given to patient while patient recovered at the pharmacy for approximately 10 minutes.  Pt fully recovered within 15 minute and was able to exit the pharmacy with her mother.
Pt started running a fever of 102.5F (oral) on 3/16/01 PM. Right deltoid (DTAP) site started swelling with a small knot. Taken her to doctor's office on 3/17/01 AM and treated with Benadryl and Tylenol.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination.The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
This spontaneous report as received from a consumer (field representative) refers to an 18 year old male patient, her son's friend. On approximately 28-MAY-2014 (reported as on either 28-MAY-2014 or 29-MAY-2014), the patient was vaccinated with two of the following three vaccines (the reporter could not determine which two they were): GARDASIL (dose, route and lot# not provided), Hepatitis A (manufacturer unknown) (dose, route and lot# not provided) and meningococcal vaccine (unspecified) (dose, route and lot# not provided). No concomitant medications were reported. The reproter reported that after receiving two of the vaccines (unspecified which two they were), the patient passed out and fell off the table in the doctor's office, then was sent to unspecified university hospital emergency room. The reporter stated that the patient broke his collar bone due to fall and had planned surgery for the collar bone on 06-JUN-2014. The outcome of events was reported as not recovered/resolved. The relatedness between the events and therapy with GARDASIL and Hepatitis A (manufacturer unknown) was not reported. Additional information has been requested.
I experienced fever, chills, body aches and headache.  They began at 3:00 am on 3/26/21.   I began to feel bettter around 8:00 pm on 3-26-21.  Upon waking on 3-27-21 I felt normal again except a small headache that then went away on 3-28-21.  Symptons did not seem to improve after taking Tylenol arthritis.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On an unknown date, the patient received an improperly stored dose of VARIVAX, dosage scheduled and route of administration were not provided (lot # M028552, expiration date 07-JUN-2018)for prophylaxis. The vaccine was exposed to -13° centigrade degrees for 72 hours. The temperatures were logged with a data logger and there were no previous excursions. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Moderna COVID-19 Vaccine EUA.  Monday, 2-15-21. 11:45 am. ? Received first dose of Moderna Covid-19 vaccine.  12:30 pm. ? Headache developed.   8:00 pm. ? Watching TV noted irregular heartbeat, and a minute later, increase in respiration rate.  That lasted 20 minutes at the most, and then went away.  Went to bed at 10 pm and slept well.  Tuesday, 2-16-21. 7:00 am. ? In kitchen. Lightheaded, increased respiration, feeling like I?m going to pass out, so I quickly sit down.  Two minutes later feel fine.  Went about making breakfast.  This happened two more times.  Realizing this might be a reaction to the vaccination, went to urgent care.  Doctor listened to my heart, ordered EKG and result showed that I was in atrial fibrillation (A-Fib).  NO previous cardiac issues, no high blook pressure, no diabetes, never a smoker, not obese.   Ambulance was called to take me to Hospital.  Another EKG confirmed still in A-Fib.  Blood drawn.  Hooked me up to a wireless/remote heart monitor.  Still in A-Fib, elevated heart rate, higher than normal blood pressure.  Kept overnight in hospital awaiting more test results, continuous monitoring, and with ECG ordered for Wednesday morning and then consultation with cardiologist.  Wednesday, 2-17-21.  11:45 am., ECG done.  Still in A-Fib. ECG shows no signs of blood pooling or clotting.  Cardiologist proposed courses of action, starting with what makes sense based on current conditions:  A cardioversion.  Having done thousands (his words) and given my great state of health otherwise, and very low risk for complications, a cardioversion is agreed to.  That would happen immediately after first doing a Tee (transesophageal echocardiography) to look at the back of my heart.  Then if all looks clear, no clotting, proceed with the cardioversion procedure.   3:00 pm., anesthesiologist asks if I have any further questions. I didn?t. He sedates me.  At 3:17 pm. I open my eyes, see the cardiologist standing at the foot of the gurney giving me thumbs up.  I returned the thumbs up and said to him, ?good job.?  Heartbeat successfully restored to normal rhythm by the cardioversion procedure.  6:00 pm. (approximately) - Discharged from hospital with prescription for Eliquis and Lopressor, and instructions for follow up appointments with primary care physician, and with cardiologist.
Patient came in for a COVID Bivalent booster on Friday 12/2/2022. He was administered a vaccine subcutaneously on his anterior left forearm.  It was determined that the vaccine was administered subcutaneously. The vaccine site has been swollen and red since 12/2/2022.  On 12/6/2022, Patient presented to the clinic, with his partner, reporting redness and induration at the vaccine site. Patient was examined by the Medical Director.   Medical Director noted in the progress note that the patient was doing well and the vaccine reaction appeared to be localized and limited to some erythema and central induration at the point of injection.  There were no signs of cellulitis, such as pain or warmth and there was no evidence of abscess or granulation.  Medical Director measured the erythematous area and provided the patient with a measuring tape to continue to monitor.  Medical Director instructed the patient to apply clean warm moist compresses to the area in hopes of a faster absorption.  It was recommended that the patient re-vaccinate against COVID once all symptoms have resolved.  Patient is to contact Medical Director if additional symptoms, either local or systemic were to appear.
POST 10 MINUTES OF RECIEVING INFLUENZA VACCINE. PATIENT DEVELOPED RASH ON TRUNK OF BODY. M.D ADMINISTERED 3/4 TSP. OF BENADRYL BY MOUTH. CHILD WAS DISCHARGE IN NO APPARENT DISTRESS. SMILING, ACTIVE, CONSCIOUS.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. There was no information about patient's concurrent medications and pertinent medical history reported. On an unknown dates, the patient was vaccinated with unspecified number of doses of unspecified varicella vaccine reported as either (Merck) VARIVAX (lots#, expiry dates, routes and sites of administration, doses were not reported) or (Merck) PROQUAD (lots#, expiry dates, routes and sites of administration, doses were not reported). On an unknown date, the patient experienced shingles an unspecified amount of times. The patient developed "just a few spots". The outcome of the event was unknown. The relatedness between the event and unspecified varicella vaccine (either (Merck) VARIVAX or (Merck) PROQUAD) was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd pneumococcal vax following vax pt devel a local reaction measuring 7-9" & 3"; reaction was characterized as being indurated, hot, erythematous & lasted for about 4 to 5 days; tx was nonspecific; No further details were provided;
Myalgia, Arthralgia, Fever, severe pain, unable to lift arm, fever, mild rash at site Narrative: Tylenol as needed
101.6 Fever, chill, headache, body ache, dizzy, nausea for 30 hours. Injection site is still red and hurts to the touch 72 hours later
My chronic condition that I have, had  flared up. I developed hives on my leg so I needed to start the Xolair medication again. I went to Dr. for the hives I had developed.
12/22/22 presents to ED for "fever". PMHx of "HTN, HLD, DM type 2, lymphoma"